Author

Qi Wu

Fourth Affiliated Hospital of Guangxi Medical University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Barbara Czako· 1 shared Changbo DaiiD· 1 shared Christopher D. SchareriD· 1 shared David A. FoxiD· 1 shared David Maxwell· 1 shared Dean E. Draayer· 1 shared Deanna DwyeriD· 1 shared Deng Lele· 1 shared

Activity by Year

2018-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 14 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Barbara Czako

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Efficient recovery of transgene-free edited tobacco using the transgene self-elimination system via de novo regeneration

Jianduo Zhang, Weiran Li, Jing Lv, Xinruitong Liu, 王萝萍, Yu Qian, Yuying Liu, Feiyan QI, Haoyi Xue, Xin Liu, Deng Lele, Fengjiao Wang, Jicang Xu, Kaili Xue, Xuepeng Liu, , Changbo Dai

This study develops a transgene self-elimination system in tobacco using CRISPR/Cas9 and BARNASE cassettes to generate transgene-free edited progeny through de novo regeneration.

bioRxiv · Oct 28, 2026 · PreprintMolecular Biology

A frozen human wound-repair reference reveals heterogeneous tumor niches and conditional immunotherapy associations

qi wu, Shuiming Jiang, Lei Liu

The paper analyzes wound-repair modules in tumors to identify heterogeneous niches and conditional immunotherapy associations.

bioRxiv · Sep 16, 2026 · PreprintImmunology

Ocrelizumab Modulates Both B and T Cell Immune Capacities in Multiple Sclerosis

Qi Wu, Mikel Gurrea‐Rubio, Q. Wang, Deanna Dwyer, Elizabeth Anne Mills, Joshua W. Garton, Joshua S Mytych, Steven K. Lundy, Christopher D. Scharer, Jeremy M. Boss, Laura A. Cooney, Dean E. Draayer, Phillip L. Campbell, David A. Fox, Yang Mao‐Draayer

This study examines how ocrelizumab affects B and T cell populations in MS patients, revealing changes in B cell subsets and T cell dynamics, along with altered signaling pathways.

bioRxiv · Mar 26, 2026 · PreprintImmunology

Eradication of ENO1-deleted Glioblastoma through Collateral Lethality

Yu-Hsi Lin, Nikunj Satani, Naima Hammoudi, Jeffrey J. Ackroyd, Sunada Khadka, Victoria C. Yan, Dimitra K. Georgiou, Yuting Sun, Rafal Zielinski, Theresa Tran, Susana Castro Pando, Xiaobo Wang, David Maxwell, Zhenghong Peng, Federica Pisaneschi, , Florian L. Muller

The paper demonstrates that POMHEX, a modified phosphonate antibiotic, effectively eradicates ENO1-deleted glioblastoma in vivo without causing hemolytic anemia.

bioRxiv · May 25, 2018 · PreprintCancer Biology